Jose Breton
Comptroller/Controller/Auditor at MINERALYS THERAPEUTICS, INC.
Profile
Jose Breton is currently working as the Senior Vice President-Finance & Controller at Mineralys Therapeutics, Inc. Previously, he held positions as the Chief Accounting Officer & Controller at Vical, Inc., the Client Manager at Global Resource Partners, Inc., and the Chief Accounting Officer & Controller at Brickell Subsidiary, Inc. He also worked as an Auditor at Deloitte LLP (New York) from 2014 to 2015.
From 2013 to 2022, he served as the Chief Accounting Officer & Controller at Fresh Tracks Therapeutics, Inc. Mr. Breton completed his undergraduate and graduate degrees at Miami University.
Jose Breton active positions
| Companies | Position | Start |
|---|---|---|
| MINERALYS THERAPEUTICS, INC. | Comptroller/Controller/Auditor | - |
Former positions of Jose Breton
| Companies | Position | End |
|---|---|---|
| FRESH TRACKS THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 2022-06-14 |
Deloitte LLP (New York)
 Deloitte LLP (New York) Miscellaneous Commercial ServicesCommercial Services Deloitte LLP (New York) engages in the provision of audit, consulting, tax, and advisory solutions. It offers services relating to tax, consulting, audit and assurance, Deloitte private company services, mergers and acquisitions, risk and financial advisory, analytics, and cloud. The company was founded by William Welch Deloitte, George A. Touche, Charles Waldo Haskins, and Elijah Watt Sells in 1845 and is headquartered in New York, NY. | Corporate Officer/Principal | 2014-12-31 |
Global Resource Partners, Inc.
 Global Resource Partners, Inc. Information Technology ServicesTechnology Services Global Resource Partners, Inc. provides computer related services. The private company is based in Cheyenne, WY. | Corporate Officer/Principal | - |
Brickell Subsidiary, Inc.
 Brickell Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology Brickell Subsidiary, Inc. operates as a clinical-stage pharmaceutical company. It focuses on the development of differentiated, innovative drug therapies for the treatment of skin diseases. The firm specializes in Hyperhidrosis, Cutaneous T-Cell Lymphoma and Psoriasis areas. The company was founded by Reginald L. Hardy and Andrew D. Sklawer in November 2009 and is headquartered in Boulder, CO. | Comptroller/Controller/Auditor | - |
Vical, Inc.
 Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA. | Comptroller/Controller/Auditor | - |
Training of Jose Breton
| Miami University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| FRESH TRACKS THERAPEUTICS, INC. | Health Technology |
| MINERALYS THERAPEUTICS, INC. | Health Technology |
| Private companies | 4 |
|---|---|
Vical, Inc.
Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA. | Health Technology |
Brickell Subsidiary, Inc.
Brickell Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology Brickell Subsidiary, Inc. operates as a clinical-stage pharmaceutical company. It focuses on the development of differentiated, innovative drug therapies for the treatment of skin diseases. The firm specializes in Hyperhidrosis, Cutaneous T-Cell Lymphoma and Psoriasis areas. The company was founded by Reginald L. Hardy and Andrew D. Sklawer in November 2009 and is headquartered in Boulder, CO. | Health Technology |
Global Resource Partners, Inc.
Global Resource Partners, Inc. Information Technology ServicesTechnology Services Global Resource Partners, Inc. provides computer related services. The private company is based in Cheyenne, WY. | Technology Services |
Deloitte LLP (New York)
Deloitte LLP (New York) Miscellaneous Commercial ServicesCommercial Services Deloitte LLP (New York) engages in the provision of audit, consulting, tax, and advisory solutions. It offers services relating to tax, consulting, audit and assurance, Deloitte private company services, mergers and acquisitions, risk and financial advisory, analytics, and cloud. The company was founded by William Welch Deloitte, George A. Touche, Charles Waldo Haskins, and Elijah Watt Sells in 1845 and is headquartered in New York, NY. | Commercial Services |
- Stock Market
- Insiders
- Jose Breton
